Galectin Therapeutics, Inc. (GALT)
3.38
+0.01
(+0.30%)
USD |
NASDAQ |
Oct 22, 16:00
3.365
-0.02
(-0.44%)
After-Hours: 20:00
Galectin Therapeutics Price : 3.38 for Oct. 22, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | 3.34 | 3.50 | 3.27 | 3.38 | 161536.0 |
| Oct 21, 2026 | 3.46 | 3.51 | 3.19 | 3.37 | 295685.0 |
| Oct 20, 2026 | 3.51 | 3.615 | 3.41 | 3.43 | 200201.0 |
| Oct 19, 2026 | 3.60 | 3.726 | 3.47 | 3.495 | 177288.0 |
| Oct 16, 2026 | 3.71 | 3.81 | 3.61 | 3.62 | 169431.0 |
| Oct 15, 2026 | 3.68 | 3.84 | 3.66 | 3.71 | 119199.0 |
| Oct 14, 2026 | 3.66 | 3.86 | 3.61 | 3.64 | 408977.0 |
| Oct 13, 2026 | 3.84 | 3.86 | 3.67 | 3.69 | 184438.0 |
| Oct 12, 2026 | 3.92 | 4.005 | 3.84 | 3.87 | 99681.00 |
| Oct 09, 2026 | 3.64 | 3.97 | 3.64 | 3.94 | 156508.0 |
| Oct 08, 2026 | 3.62 | 3.69 | 3.510 | 3.64 | 270887.0 |
| Oct 07, 2026 | 3.74 | 3.86 | 3.59 | 3.62 | 176015.0 |
| Oct 06, 2026 | 3.75 | 3.79 | 3.57 | 3.76 | 277933.0 |
| Oct 05, 2026 | 3.84 | 3.899 | 3.64 | 3.73 | 280835.0 |
| Oct 02, 2026 | 3.82 | 3.94 | 3.75 | 3.90 | 220511.0 |
| Oct 01, 2026 | 3.87 | 4.055 | 3.68 | 3.76 | 327425.0 |
| Sep 30, 2026 | 3.90 | 4.05 | 3.824 | 3.88 | 198083.0 |
| Sep 29, 2026 | 3.94 | 4.00 | 3.90 | 3.91 | 174410.0 |
| Sep 28, 2026 | 3.86 | 3.99 | 3.80 | 3.93 | 168755.0 |
| Sep 25, 2026 | 3.93 | 3.99 | 3.86 | 3.90 | 124617.0 |
| Sep 24, 2026 | 4.00 | 4.040 | 3.780 | 3.96 | 153324.0 |
| Sep 23, 2026 | 4.12 | 4.15 | 4.00 | 4.05 | 174131.0 |
| Sep 22, 2026 | 4.05 | 4.24 | 4.050 | 4.14 | 258069.0 |
| Sep 21, 2026 | 3.91 | 4.02 | 3.85 | 3.96 | 258378.0 |
| Sep 18, 2026 | 3.71 | 3.92 | 3.68 | 3.89 | 1.066M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Mirum Pharmaceuticals, Inc. | 83.10 |
| ACADIA Pharmaceuticals, Inc. | 20.31 |
| Alnylam Pharmaceuticals, Inc. | 227.28 |
| Anika Therapeutics, Inc. | 21.09 |
| Savara, Inc. | 4.54 |
Price Related Metrics
| Earnings Yield | -12.71% |
| Market Cap | 224.13M |